July 25, 2014 11:14 AM ET

Pharmaceuticals

Company Overview of Adagio Pharmaceuticals Ltd.

Company Overview

Adagio Pharmaceuticals Ltd. owns and operates intellectual property relating to APL-130277, a reformulation of an approved Parkinson's drug. The company is based in Oakville, Canada. As of December 22, 2011, Adagio Pharmaceuticals Ltd. operates as a subsidiary of Cynapsus Therapeutics Inc.

1302 Kestell Boulevard

Oakville, ON L6H 0B9

Canada

Key Executives for Adagio Pharmaceuticals Ltd.

Adagio Pharmaceuticals Ltd. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Sandoz Canada Inc. Americas
Allergan Inc. (Canada) Americas
Cronus BioPharma Inc. Americas
Mylan Pharmaceuticals ULC Americas
Bioniche Animal Health Canada Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Adagio Pharmaceuticals Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.